Treatment of myelodysplastic syndromes with AML-type chemotherapy

Leuk Lymphoma. 1993:11 Suppl 2:59-63. doi: 10.3109/10428199309064263.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chromosome Aberrations
  • Cytarabine / administration & dosage
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Idarubicin / administration & dosage
  • Karyotyping
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics
  • Prognosis
  • Remission Induction
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vidarabine
  • fludarabine
  • Idarubicin